BIOMARKER DETECTION STUDIES

Assessing candidate therapeutics and aiding in the development of companion diagnostics with state-of-the-art biomarker detection studies.

AN OUNCE OF PREVENTION IS WORTH A POUND OF CURE

Prevention isn’t always an option, however. Most of the time, it isn’t. In that case, early detection is what matters: Breast cancer, when detected early on, increases the 5 year survival rate of patients suffering from it by a whopping 93%[1]. Detecting an outbreak at its early stages might save the world from Disease-X[2].

This is where biomarkers shine: An early and timely detection of disease biomarkers can mitigate and even prevent the spread of infectious diseases, the development of cancers, and more. You can check out our available biomarker detection models, and if you have any questions, our team of experts is ready to assist you 24/7.

 

Ensuring superior quality:

  • Electronically managed, traceable research data
  • 150,000 square feet of facility space
  • FDA Part 11 compliant
  • 600+ validated animal models of disease spanning 40+ diseases
quality section

Never settle for less in your histopathology studies. Contact PharmaLegacy now.